SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Multiple Sclerosis
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Selkirk, S. M
Right arrow Articles by Shi, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Selkirk, S. M
Right arrow Articles by Shi, J.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*MRI Scans
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Relapsing-remitting tumefactive multiple sclerosis

Stephen M Selkirk

Department of Neurology, University Hospital of Cleveland, 11100 Euclid Avenue, Cleveland, OH 44106, USA, stephen_selkirk{at}hotmail.com

Jiong Shi

Department of Neurology, University Hospital of Cleveland, 11100 Euclid Avenue, Cleveland, OH 44106, USA

Tumefactive multiple sclerosis (MS) is a rare form of demyelinating disease. The natural course of the disease has been characterized as presenting with a mass-like demyelinating lesion converting to typical relapsing-remitting disease with future exacerbations. Herein we describe a case of a patient whom over a six-year period developed relapsing-remitting tumefactive MS. The natural course, pathophysiology, prognosis and diagnosis are briefly discussed.

Key Words: brain • central nervou system • demyelination • multiple sclerosis • tumefactive • tumour

Multiple Sclerosis, Vol. 11, No. 6, 731-734 (2005)
DOI: 10.1191/1352458505ms1214cr
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 RadiologyHome page
D. S. Kim, D. G. Na, K. H. Kim, J.-h. Kim, E. Kim, B. L. Yun, and K.-H. Chang
Distinguishing Tumefactive Demyelinating Lesions from Glioma or Central Nervous System Lymphoma: Added Value of Unenhanced CT Compared with Conventional Contrast-enhanced MR Imaging
Radiology, May 1, 2009; 251(2): 467 - 475.
[Abstract] [Full Text] [PDF]

Home page
 J Child NeurolHome page
J. Dastgir and F. J. DiMario Jr
Acute Tumefactive Demyelinating Lesions in a Pediatric Patient With Known Diagnosis of Multiple Sclerosis: Review of the Literature and Treatment Proposal
J Child Neurol, April 1, 2009; 24(4): 431 - 437.
[Abstract] [PDF]

Home page
 Am. J. Neuroradiol.Home page
J. Sanahuja, S. Ordonez-Palau, R. Begue, L. Brieva, and D. Boquet
Primary Sjogren Syndrome with Tumefactive Central Nervous System Involvement
AJNR Am. J. Neuroradiol., November 1, 2008; 29(10): 1878 - 1879.
[Abstract] [Full Text] [PDF]


Advertisement